The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I agree and been happy to top up at these levels
Yes really hope so, Clive does have a successful track record, but as the saying goes, unfortunately, previous successes do not translate to future success just look at Neil Woodford ?? . IL 17 does look exciting, lets see how the progress over the coming months... it's a race to find a solution. Hope c4x can find it first.
I understand that timelines have been rather optimistic after listening to the podcasts etc over the past few years! However, Clive has shown he is able to get deals over the line and looking at his success rate at other companies points to more success here! This type of company will take time but the current valuation is ludicrous considering the IP value and the potential of the compounds developed! IL 17 sounds like it’s going to be massive
That’s cos a lot of big talk and promises made by CEO and investors patience are wearing thin on lack of action with walking the talk. Hopeful a nrf2 deal getting over the line but essentially it is whether there are enough interested buyers willing to pay big money and invest c4x developed nrf2 molecule.
I’m actually really surprised at the lack of interest here! Thought loads more would be averaging down after the massively discounted placing! I suspect interest will build through March and April in the expectation of NRF2 getting over the line! Got to be a smashing entry at this price!
Make or break this year. Huge bet on whether this NRf2 compounds for SCD can attract an out license deal. The price movement will rest on this deal. Expecting more data generated by Q1 on candidate selection of NRf2 compounds since as it stands the data is not good enough otherwise a deal would have gone through by now. If we don't see any news by H1... it will be testing times for the share price as cash burn is significant.
to move this significantly either way, so if/when buyers return and positive news circulates we could well see a good return from here, however many will be under water until we get back to at least 50p range